BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smith RA, Andrews K, Brooks D, DeSantis CE, Fedewa SA, Lortet-Tieulent J, Manassaram-Baptiste D, Brawley OW, Wender RC. Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 2016;66:96-114. [PMID: 26797525 DOI: 10.3322/caac.21336] [Cited by in Crossref: 133] [Cited by in F6Publishing: 137] [Article Influence: 22.2] [Reference Citation Analysis]
Number Citing Articles
1 Chagas CM, Moss S, Alisaraie L. Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski’s Rule of Five. International Journal of Pharmaceutics 2018;549:133-49. [DOI: 10.1016/j.ijpharm.2018.07.046] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
2 Ha DM, Zeng C, Chan ED, Gray M, Mazzone PJ, Samet JM, Steiner JF. Association of Exercise Behavior with Overall Survival in Stage I-IIIA Lung Cancer. Ann Am Thorac Soc 2021;18:1034-42. [PMID: 33326358 DOI: 10.1513/AnnalsATS.202003-235OC] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Meireles CG, Pereira SA, Valadares LP, Rêgo DF, Simeoni LA, Guerra ENS, Lofrano-Porto A. Effects of metformin on endometrial cancer: Systematic review and meta-analysis. Gynecol Oncol 2017;147:167-80. [PMID: 28760367 DOI: 10.1016/j.ygyno.2017.07.120] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 8.6] [Reference Citation Analysis]
4 Cheng HH, Pritchard CC, Montgomery B, Lin DW, Nelson PS. Prostate Cancer Screening in a New Era of Genetics. Clin Genitourin Cancer 2017;15:625-8. [PMID: 28697982 DOI: 10.1016/j.clgc.2017.05.024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
5 Prince M, Lester L, Chiniwala R, Berger B. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients. World J Gastroenterol 2017; 23(3): 464-471 [PMID: 28210082 DOI: 10.3748/wjg.v23.i3.464] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
6 Maicas G, Carneiro G, Bradley AP, Nascimento JC, Reid I. Deep Reinforcement Learning for Active Breast Lesion Detection from DCE-MRI. In: Descoteaux M, Maier-hein L, Franz A, Jannin P, Collins DL, Duchesne S, editors. Medical Image Computing and Computer Assisted Intervention − MICCAI 2017. Cham: Springer International Publishing; 2017. pp. 665-73. [DOI: 10.1007/978-3-319-66179-7_76] [Cited by in Crossref: 32] [Cited by in F6Publishing: 6] [Article Influence: 6.4] [Reference Citation Analysis]
7 Bakr O, Afsar-Manesh N, Raja N, Dermenchyan A, Goldstein NJ, Shu SB, May FP. Application of Behavioral Economics Principles Improves Participation in Mailed Outreach for Colorectal Cancer Screening. Clin Transl Gastroenterol 2020;11:e00115. [PMID: 31972609 DOI: 10.14309/ctg.0000000000000115] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Shen L, Zhang SQ, Liu L, Sun Y, Wu YX, Xie LP, Liu JC. Jolkinolide A and Jolkinolide B Inhibit Proliferation of A549 Cells and Activity of Human Umbilical Vein Endothelial Cells. Med Sci Monit 2017;23:223-37. [PMID: 28087861 DOI: 10.12659/msm.902704] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
9 Kotwal AA, Walter LC, Lee SJ, Dale W. Are We Choosing Wisely? Older Adults' Cancer Screening Intentions and Recalled Discussions with Physicians About Stopping. J Gen Intern Med 2019;34:1538-45. [PMID: 31147981 DOI: 10.1007/s11606-019-05064-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Shim SH, Kim H, Sohn IS, Hwang HS, Kwon HS, Lee SJ, Lee JY, Kim SN, Lee K, Chang S. Nationwide cervical cancer screening in Korea: data from the National Health Insurance Service Cancer Screening Program and National Cancer Screening Program, 2009-2014. J Gynecol Oncol 2017;28:e63. [PMID: 28657224 DOI: 10.3802/jgo.2017.28.e63] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
11 da Costa Vieira RA, Biller G, Uemura G, Ruiz CA, Curado MP. Breast cancer screening in developing countries. Clinics (Sao Paulo) 2017;72:244-53. [PMID: 28492725 DOI: 10.6061/clinics/2017(04)09] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 9.4] [Reference Citation Analysis]
12 Liu Z, Lin C, Mu L, Suo C, Ye W, Jin L, Franceschi S, Zhang T, Chen X. The disparities in gastrointestinal cancer incidence among Chinese populations in Shanghai compared to Chinese immigrants and indigenous non‐Hispanic white populations in Los Angeles, USA. Int J Cancer 2019;146:329-40. [DOI: 10.1002/ijc.32251] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kim NH, Yang H, Park S, Park JH, Park DI, Sohn CI, Choi K, Jung YS. Does Low Threshold Value Use Improve Proximal Neoplasia Detection by Fecal Immunochemical Test? Dig Dis Sci 2016;61:2685-93. [DOI: 10.1007/s10620-016-4169-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
14 Fliss-Isakov N, Zelber-Sagi S, Webb M, Halpern Z, Shibolet O, Kariv R. Distinct Metabolic Profiles are Associated with Colorectal Adenomas and Serrated Polyps. Obesity (Silver Spring) 2017;25 Suppl 2:S72-80. [PMID: 29086511 DOI: 10.1002/oby.22001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
15 Tergas AI, Wright JD. Cancer Prevention Strategies for Women. Obstet Gynecol 2019;134:30-43. [PMID: 31135701 DOI: 10.1097/AOG.0000000000003304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Tian BR, Lin WF, Zhang Y. Effects of biomechanical forces on the biological behavior of cancer stem cells. J Cancer 2021;12:5895-902. [PMID: 34476003 DOI: 10.7150/jca.60893] [Reference Citation Analysis]
17 Gao P, Wang X, Bai P, Kong X, Wang Z, Fang Y, Wang J. Clinical outcomes and patient satisfaction with the use of biological and synthetic meshes in one-stage implant-based breast reconstruction. Breast Cancer 2022. [PMID: 34978672 DOI: 10.1007/s12282-021-01324-y] [Reference Citation Analysis]
18 Beane J, Campbell JD, Lel J, Vick J, Spira A. Genomic approaches to accelerate cancer interception. Lancet Oncol 2017;18:e494-502. [PMID: 28759388 DOI: 10.1016/S1470-2045(17)30373-X] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 5.2] [Reference Citation Analysis]
19 Miao L, Liu HY, Zhou C, He X. LINC00612 enhances the proliferation and invasion ability of bladder cancer cells as ceRNA by sponging miR-590 to elevate expression of PHF14. J Exp Clin Cancer Res 2019;38:143. [PMID: 30940184 DOI: 10.1186/s13046-019-1149-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
20 Dobbs RW, Greenwald DT, Wadhwa H, Freeman VL, Abern MR. Is prostate cancer stage migration continuing for black men in the PSA era? Prostate Cancer Prostatic Dis 2017;20:210-5. [DOI: 10.1038/pcan.2016.68] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
21 Jin F, Luo HL, Zhou J, He YN, Liu XF, Zhong MS, Yang H, Li C, Li QC, Huang X, Tian XM, Qiu D, He GL, Yin L, Wang Y. Cancer risk assessment in modern radiotherapy workflow with medical big data. Cancer Manag Res 2018;10:1665-75. [PMID: 29970965 DOI: 10.2147/CMAR.S164980] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
22 Utida GM, Kulak J Jr. Hysteroscopic and aspiration biopsies in the histologic evaluation of the endometrium, a comparative study. Medicine (Baltimore) 2019;98:e17183. [PMID: 31577708 DOI: 10.1097/MD.0000000000017183] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Barry MJ, Simmons LH. Prevention of Prostate Cancer Morbidity and Mortality: Primary Prevention and Early Detection. Med Clin North Am 2017;101:787-806. [PMID: 28577627 DOI: 10.1016/j.mcna.2017.03.009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 10.4] [Reference Citation Analysis]
24 Jiang M, Jin S, Han J, Li T, Shi J, Zhong Q, Li W, Tang W, Huang Q, Zong H. Detection and clinical significance of circulating tumor cells in colorectal cancer. Biomark Res 2021;9:85. [PMID: 34798902 DOI: 10.1186/s40364-021-00326-4] [Reference Citation Analysis]
25 González LA, Alarcón GS. The evolving concept of SLE comorbidities. Expert Review of Clinical Immunology 2017;13:753-68. [DOI: 10.1080/1744666x.2017.1327353] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
26 Cleophat JE, Nabi H, Pelletier S, Bouchard K, Dorval M. What characterizes cancer family history collection tools? A critical literature review. Curr Oncol 2018;25:e335-50. [PMID: 30111980 DOI: 10.3747/co.25.4042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
27 Guo C, Yeh S, Niu Y, Li G, Zheng J, Li L, Chang C. Targeting androgen receptor versus targeting androgens to suppress castration resistant prostate cancer. Cancer Letters 2017;397:133-43. [DOI: 10.1016/j.canlet.2017.03.022] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
28 Woythal N, Arsenic R, Kempkensteffen C, Miller K, Janssen JC, Huang K, Makowski MR, Brenner W, Prasad V. Immunohistochemical Validation of PSMA Expression Measured by 68Ga-PSMA PET/CT in Primary Prostate Cancer. J Nucl Med 2018;59:238-43. [PMID: 28775203 DOI: 10.2967/jnumed.117.195172] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 10.6] [Reference Citation Analysis]
29 Hwang SH, Shin HY, Lee DO, Sung NY, Lee B, Lee DH, Jun JK. A prospective pilot evaluation of vaginal and urine self-sampling for the Roche cobas 4800 HPV test for cervical cancer screening. Sci Rep 2018;8:9015. [PMID: 29899531 DOI: 10.1038/s41598-018-27390-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Jaffee EM, Dang CV, Agus DB, Alexander BM, Anderson KC, Ashworth A, Barker AD, Bastani R, Bhatia S, Bluestone JA, Brawley O, Butte AJ, Coit DG, Davidson NE, Davis M, DePinho RA, Diasio RB, Draetta G, Frazier AL, Futreal A, Gambhir SS, Ganz PA, Garraway L, Gerson S, Gupta S, Heath J, Hoffman RI, Hudis C, Hughes-Halbert C, Ibrahim R, Jadvar H, Kavanagh B, Kittles R, Le QT, Lippman SM, Mankoff D, Mardis ER, Mayer DK, McMasters K, Meropol NJ, Mitchell B, Naredi P, Ornish D, Pawlik TM, Peppercorn J, Pomper MG, Raghavan D, Ritchie C, Schwarz SW, Sullivan R, Wahl R, Wolchok JD, Wong SL, Yung A. Future cancer research priorities in the USA: a Lancet Oncology Commission. Lancet Oncol 2017;18:e653-706. [PMID: 29208398 DOI: 10.1016/S1470-2045(17)30698-8] [Cited by in Crossref: 83] [Cited by in F6Publishing: 35] [Article Influence: 16.6] [Reference Citation Analysis]
31 Lee JH, Lee H, Kim K, Lee SW, Song JH, Hwang SD. Cancer Diagnosis During Kidney Donor Evaluation. Transplantation Proceedings 2022. [DOI: 10.1016/j.transproceed.2021.10.021] [Reference Citation Analysis]
32 Nagai Y, Sunami E, Yamamoto Y, Hata K, Okada S, Murono K, Yasuda K, Otani K, Nishikawa T, Tanaka T, Kiyomatsu T, Kawai K, Nozawa H, Ishihara S, Hoon DS, Watanabe T. LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer. Oncotarget 2017;8:11906-16. [PMID: 28060757 DOI: 10.18632/oncotarget.14439] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 7.6] [Reference Citation Analysis]
33 Wang Q, Zhou D, Wu F, Liang Q, He Q, Peng M, Yao T, Hu Y, Qian B, Tang J, Wang X, Liu W, Yu F, Chen C. Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer. Front Oncol 2021;11:680287. [PMID: 34395248 DOI: 10.3389/fonc.2021.680287] [Reference Citation Analysis]
34 Pearlstein KA, Basak R, Chen RC. Cardiovascular Care Among Cancer Survivors in the United States. JNCI Cancer Spectr 2018;2:pky049. [PMID: 31360872 DOI: 10.1093/jncics/pky049] [Reference Citation Analysis]
35 Warner EL, Bodson J, Mooney R, Lai D, Samadder NJ, Kepka D. Latinas' Colorectal Cancer Screening Knowledge, Barriers to Receipt, and Feasibility of Home-Based Fecal Immunochemical Testing. J Immigr Minor Health 2018;20:981-90. [PMID: 28646404 DOI: 10.1007/s10903-017-0615-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
36 Patel K, Gishe J, Liu J, Heaston A, Manis E, Moharreri B, Hargreaves M. Factors Influencing Recommended Cancer Screening in Low-Income African American Women in Tennessee. J Racial Ethn Health Disparities 2020;7:129-36. [PMID: 31664677 DOI: 10.1007/s40615-019-00642-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Ahmed M, Aslam M. Serum MACC-1: a new biomarker for breast cancer. Oncotarget 2020;11:4521-6. [PMID: 33400729 DOI: 10.18632/oncotarget.27813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Besharati F, Karimi-Shahanjarini A, Hazavehei SMM, Bashirian S, Bagheri F, Faradmal J. Development of a Colorectal Cancer Screening Intervention for Iranian Adults: Appling Intervention Mapping. Asian Pac J Cancer Prev 2017;18:2193-9. [PMID: 28843255 DOI: 10.22034/APJCP.2017.18.8.2193] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
39 Masoudiyekta L, Rezaei-Bayatiyani H, Dashtbozorgi B, Gheibizadeh M, Malehi AS, Moradi M. Effect of Education Based on Health Belief Model on the Behavior of Breast Cancer Screening in Women. Asia Pac J Oncol Nurs. 2018;5:114-120. [PMID: 29379843 DOI: 10.4103/apjon.apjon_36_17] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
40 Yábar A, Meléndez R, Muñoz S, Deneo H, Freire J, Domínguez V, Carrasco-Navarro RM, Diaz ME, Velarde-López RE. Effect of Ki-67 assessment in the distribution of breast cancer subtypes: Evaluation in a cohort of Latin American patients. Mol Clin Oncol 2017;6:503-9. [PMID: 28413656 DOI: 10.3892/mco.2017.1185] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
41 Wood B, Lofters A, Vahabi M. Strategies to reach marginalized women for cervical cancer screening: A qualitative study of stakeholder perspectives. Curr Oncol 2018;25:e8-e16. [PMID: 29507490 DOI: 10.3747/co.25.3851] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
42 Dantal J, Campone M. Daunting but Worthy Goal: Reducing the De Novo Cancer Incidence After Transplantation. Transplantation 2016;100:2569-83. [PMID: 27861286 DOI: 10.1097/TP.0000000000001428] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
43 Castro J, Sanchez L, Nuñez MT, Lu M, Castro T, Sharifi HR, Ericsson C. Screening Circulating Tumor Cells as a Noninvasive Cancer Test in 3388 Individuals from High-Risk Groups (ICELLATE2). Dis Markers 2018;2018:4653109. [PMID: 29997714 DOI: 10.1155/2018/4653109] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
44 Zhu W, Sheng D, Shao Y, Zhang Q, Peng Y. STAT3-regulated LncRNA LINC00160 mediates cell proliferation and cell metabolism of prostate cancer cells by repressing RCAN1 expression. Mol Cell Biochem 2022. [PMID: 35067783 DOI: 10.1007/s11010-021-04284-1] [Reference Citation Analysis]
45 Song LD, Newhouse JP, Garcia-De-Albeniz X, Hsu J. Changes in screening colonoscopy following Medicare reimbursement and cost-sharing changes. Health Serv Res 2019;54:839-50. [PMID: 30941767 DOI: 10.1111/1475-6773.13150] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
46 Chen H, Krishnamachari S, Guo J, Yao L, Murugan P, Weight CJ, Turesky RJ. Quantitation of Lipid Peroxidation Product DNA Adducts in Human Prostate by Tandem Mass Spectrometry: A Method That Mitigates Artifacts. Chem Res Toxicol 2019;32:1850-62. [PMID: 31361128 DOI: 10.1021/acs.chemrestox.9b00181] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
47 Yang J, Liu X, Shu J, Hou Y, Chen M, Yu H, Ma T, Du H, Zhang J, Qiao Y, He J, Niu L, Yang F, Li Z. Abnormal Galactosylated-Glycans recognized by Bandeiraea Simplicifolia Lectin I in saliva of patients with breast Cancer. Glycoconj J 2020;37:373-94. [PMID: 32103424 DOI: 10.1007/s10719-020-09910-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
48 Martín-Sánchez E, Mendaza S, Ulazia-Garmendia A, Monreal-Santesteban I, Blanco-Luquin I, Córdoba A, Vicente-García F, Pérez-Janices N, Escors D, Megías D, López-Serra P, Esteller M, Illarramendi JJ, Guerrero-Setas D. CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer. Oncotarget 2017;8:15789-801. [PMID: 28178655 DOI: 10.18632/oncotarget.15004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
49 Lin X, Wang S, Sun M, Zhang C, Wei C, Yang C, Dou R, Liu Q, Xiong B. miR-195-5p/NOTCH2-mediated EMT modulates IL-4 secretion in colorectal cancer to affect M2-like TAM polarization. J Hematol Oncol 2019;12:20. [PMID: 30808369 DOI: 10.1186/s13045-019-0708-7] [Cited by in Crossref: 45] [Cited by in F6Publishing: 56] [Article Influence: 15.0] [Reference Citation Analysis]
50 Fasolato C, Giantulli S, Capocefalo A, Toumia Y, Notariello D, Mazzarda F, Silvestri I, Postorino P, Domenici F. Antifolate SERS-active nanovectors: quantitative drug nanostructuring and selective cell targeting for effective theranostics. Nanoscale 2019;11:15224-33. [DOI: 10.1039/c9nr01075k] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
51 Smith SR, Khanna A, Wisotzky EM. An Evolving Role for Cancer Rehabilitation in the Era of Low-Dose Lung Computed Tomography Screening. PM&R 2017;9:S407-14. [DOI: 10.1016/j.pmrj.2017.06.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
52 Schwartz LA, Henry-Moss D, Egleston B, Patrick-Miller L, Markman E, Daly M, Tuchman L, Moore C, Rauch PK, Karpink K, Sands CB, Domchek SM, Bradbury AR. Preventative Health and Risk Behaviors Among Adolescent Girls With and Without Family Histories of Breast Cancer. J Adolesc Health 2019;64:116-23. [PMID: 30301677 DOI: 10.1016/j.jadohealth.2018.07.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
53 Henderson LM, Jones LM, Marsh MW, Brenner AT, Goldstein AO, Benefield TS, Greenwood-Hickman MA, Molina PL, Rivera MP, Reuland DS. Opinions, practice patterns, and perceived barriers to lung cancer screening among attending and resident primary care physicians. Risk Manag Healthc Policy 2017;10:189-95. [PMID: 29403320 DOI: 10.2147/RMHP.S143152] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
54 Yu C, Skootsky S, Grossman M, Garner OB, Betlachin A, Esrailian E, Hommes DW, May FP. A Multi-Level Fit-Based Quality Improvement Initiative to Improve Colorectal Cancer Screening in a Managed Care Population. Clin Transl Gastroenterol 2018;9:177. [PMID: 30177700 DOI: 10.1038/s41424-018-0046-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
55 Lv YH, Li XQ, Yue CW, Wang M. Application of genome editing technologies in gastrointestinal cancers. Shijie Huaren Xiaohua Zazhi 2016; 24(36): 4772-4780 [DOI: 10.11569/wcjd.v24.i36.4772] [Reference Citation Analysis]
56 Ren L, Mo W, Wang L, Wang X. Matrine suppresses breast cancer metastasis by targeting ITGB1 and inhibiting epithelial-to-mesenchymal transition. Exp Ther Med 2020;19:367-74. [PMID: 31853313 DOI: 10.3892/etm.2019.8207] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Elshazly AAA, Desouky MN, Diab IH, Ibrahim AMA, Dwedar FI. Serum Long-Noncoding RNA H19 and β-Catenin as Biomarkers for Early Diagnosis of Colorectal Cancer in Egyptian Patients: A Case Control Study. Journal of Coloproctology. [DOI: 10.1055/s-0042-1742668] [Reference Citation Analysis]
58 Beyer SE, McKee BJ, Regis SM, McKee AB, Flacke S, El Saadawi G, Wald C. Automatic Lung-RADS™ classification with a natural language processing system. J Thorac Dis 2017;9:3114-22. [PMID: 29221286 DOI: 10.21037/jtd.2017.08.13] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
59 Owens OL, Tavakoli AS, Rose T, Wooten NR. Development and Psychometric Properties of a Prostate Cancer Knowledge Scale for African American Men. Am J Mens Health 2019;13:1557988319892459. [PMID: 31849259 DOI: 10.1177/1557988319892459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Zhang Y, Wang C, Jin Y, Yang Q, Meng Q, Liu Q, Dai Y, Cai L, Liu Z, Liu K, Sun H. Activating the PGC-1α/TERT Pathway by Catalpol Ameliorates Atherosclerosis via Modulating ROS Production, DNA Damage, and Telomere Function: Implications on Mitochondria and Telomere Link. Oxid Med Cell Longev 2018;2018:2876350. [PMID: 30046372 DOI: 10.1155/2018/2876350] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
61 Dutta A, Panja S, Virk RK, Kim JY, Zott R, Cremers S, Golombos DM, Liu D, Mosquera JM, Mostaghel EA, Barbieri CE, Mitrofanova A, Abate-Shen C. Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition. Eur Urol 2017;72:499-506. [PMID: 28385453 DOI: 10.1016/j.eururo.2017.03.031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
62 Yang J, Zhao X, Tang M, Li L, Lei Y, Cheng P, Guo W, Zheng Y, Wang W, Luo N, Peng Y, Tong A, Wei Y, Nie C, Yuan Z. The role of ROS and subsequent DNA-damage response in PUMA-induced apoptosis of ovarian cancer cells. Oncotarget 2017;8:23492-506. [PMID: 28423586 DOI: 10.18632/oncotarget.15626] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
63 Lodi M, Scheer L, Reix N, Heitz D, Carin AJ, Thiébaut N, Neuberger K, Tomasetto C, Mathelin C. Breast cancer in elderly women and altered clinico-pathological characteristics: a systematic review. Breast Cancer Res Treat 2017;166:657-68. [PMID: 28803352 DOI: 10.1007/s10549-017-4448-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
64 Jahn B, Todorovic J, Bundo M, Sroczynski G, Conrads-Frank A, Rochau U, Endel G, Wilbacher I, Malbaski N, Popper N, Chhatwal J, Greenberg D, Mauskopf J, Siebert U. Budget Impact Analysis of Cancer Screening: A Methodological Review. Appl Health Econ Health Policy 2019;17:493-511. [PMID: 31016686 DOI: 10.1007/s40258-019-00475-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
65 Lee JM, Lee JH, Kim ES, Lee JM, Yoo IK, Kim SH, Choi HS, Keum B, Seo YS, Jeen YT, Lee HS, Chun HJ, Um SH, Kim CD. The safety and effectiveness of 2-liter polyethylene glycol plus ascorbic acid in patients with liver cirrhosis: A retrospective observational study. Medicine (Baltimore) 2017;96:e9011. [PMID: 29390432 DOI: 10.1097/MD.0000000000009011] [Reference Citation Analysis]
66 Ponomaryova AA, Rykova EY, Gervas PA, Cherdyntseva NV, Mamedov IZ, Azhikina TL. Aberrant Methylation of LINE-1 Transposable Elements: A Search for Cancer Biomarkers. Cells 2020;9:E2017. [PMID: 32887319 DOI: 10.3390/cells9092017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
67 Joukar F, Ahmadnia Z, Atrkar-Roushan Z, Hasavari F, Rahimi A. The Investigation of Risk Factors Impacting Breast Cancer in Guilan Province. Asian Pac J Cancer Prev 2016;17:4623-9. [PMID: 27892674 DOI: 10.22034/apjcp.2016.17.10.4623] [Reference Citation Analysis]
68 Ha D, Ries AL, Lippman SM, Fuster MM. Effects of curative-intent lung cancer therapy on functional exercise capacity and patient-reported outcomes. Support Care Cancer 2020;28:4707-20. [PMID: 31965306 DOI: 10.1007/s00520-020-05294-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
69 Wilton KM, Matteson EL. Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis. Rheumatol Ther 2017;4:333-47. [PMID: 28508282 DOI: 10.1007/s40744-017-0064-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
70 Nakamura K, Peng Y, Utsumi F, Tanaka H, Mizuno M, Toyokuni S, Hori M, Kikkawa F, Kajiyama H. Novel Intraperitoneal Treatment With Non-Thermal Plasma-Activated Medium Inhibits Metastatic Potential of Ovarian Cancer Cells. Sci Rep 2017;7:6085. [PMID: 28729634 DOI: 10.1038/s41598-017-05620-6] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 11.4] [Reference Citation Analysis]
71 Lipkus IM, Johnson C, Amarasekara S, Pan W, Updegraff JA. Predicting Colorectal Cancer Screening among Adults Who Have Never Been Screened: Testing the Interaction between Message Framing and Tailored Risk Feedback. J Health Commun 2019;24:262-70. [PMID: 30958101 DOI: 10.1080/10810730.2019.1597950] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
72 Shankar A, Saini D, Dubey A, Roy S, Bharati SJ, Singh N, Khanna M, Prasad CP, Singh M, Kumar S, Sirohi B, Seth T, Rinki M, Mohan A, Guleria R, Rath GK. Feasibility of lung cancer screening in developing countries: challenges, opportunities and way forward. Transl Lung Cancer Res 2019;8:S106-21. [PMID: 31211111 DOI: 10.21037/tlcr.2019.03.03] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
73 Polverini PJ, Lingen MW. A History of Innovations in the Diagnosis and Treatment of Oral and Head and Neck Cancer. J Dent Res 2019;98:489-97. [PMID: 31008698 DOI: 10.1177/0022034519833645] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Wang R, Tian H, Guo D, Tian Q, Yao T, Kong X. Impacts of exercise intervention on various diseases in rats. J Sport Health Sci 2020;9:211-27. [PMID: 32444146 DOI: 10.1016/j.jshs.2019.09.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
75 Gu L, Cui P, Xing L, He Y, Chang X, Zhou T, Liu Y, Li L, Jiang H. An energy-blocking nanoparticle decorated with anti-VEGF antibody to reverse chemotherapeutic drug resistance. RSC Adv 2019;9:12110-23. [DOI: 10.1039/c9ra01356c] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
76 Dai L, Li J, Dong Z, Liu Y, Chen Y, Chen N, Cheng L, Fang C, Wang H, Ji Y, Chen S, Su X, Shi G, Lin Y, Zhang S, Yang Y, Qiu M, Yu D, Huang W, Zhou Z, Wei Y, Deng H. Temporal expression and functional analysis of long non-coding RNAs in colorectal cancer initiation. J Cell Mol Med 2019;23:4127-38. [PMID: 30920116 DOI: 10.1111/jcmm.14300] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
77 Yang NN, Huang YF, Sun J, Chen Y, Tang ZM, Jiang JF. Meta-analysis of XRCC1 polymorphism and risk of female reproductive system cancer. Oncotarget 2017;8:28455-62. [PMID: 28415705 DOI: 10.18632/oncotarget.16090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Lai D, Bodson J, Warner EL, Ayres S, Mooney R, Kepka D. Younger Age and Health Beliefs Associated with Being Overdue for Pap Testing among Utah Latinas who were Non-Adherent to Cancer Screening Guidelines. J Immigrant Minority Health 2017;19:1088-99. [DOI: 10.1007/s10903-017-0559-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
79 Neeser K, O'neil WM, Stern L, Harrow B, Travers K. Budget impact of niraparib as maintenance treatment in recurrent ovarian cancer following platinum-based chemotherapy. Journal of Comparative Effectiveness Research 2019;8:577-87. [DOI: 10.2217/cer-2018-0069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
80 Martín-Sánchez E, Mendaza S, Ulazia-Garmendia A, Monreal-Santesteban I, Córdoba A, Vicente-García F, Blanco-Luquin I, De La Cruz S, Aramendia A, Guerrero-Setas D. CDH22 hypermethylation is an independent prognostic biomarker in breast cancer. Clin Epigenetics 2017;9:7. [PMID: 28149335 DOI: 10.1186/s13148-016-0309-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
81 Handy JR Jr, Skokan M, Rauch E, Zinck S, Sanborn RE, Kotova S, Wang M. Results of Lung Cancer Screening in the Community. Ann Fam Med 2020;18:243-9. [PMID: 32393560 DOI: 10.1370/afm.2519] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Zhang Y, Zeng X, Deng H, Ma F, Peng Y, Yi L, Tan C, Peng L. Cost-Effectiveness Analysis of Adding Palbociclib as a Second-Line Endocrine Therapy for HR+/HER2- Metastatic Breast Cancer From the US and Chinese Perspectives. Clin Ther 2019;41:1175-85. [PMID: 31104762 DOI: 10.1016/j.clinthera.2019.04.033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
83 Feng Y, Xia J, Xu X, Zhao T, Tan Z, Wang Q, Wang J, Meng J, Sanderson C, Lu Z, Yang Y. Sesquiterpene lactone Bigelovin induces apoptosis of colon cancer cells through inducing IKK-β degradation and suppressing nuclear factor kappa B activation. Anticancer Drugs 2021;32:664-73. [PMID: 33929997 DOI: 10.1097/CAD.0000000000001073] [Reference Citation Analysis]
84 McIntyre A, Ganti AK. Lung cancer-A global perspective. J Surg Oncol 2017;115:550-4. [PMID: 28418583 DOI: 10.1002/jso.24532] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 6.4] [Reference Citation Analysis]
85 Ritter A, Hirschfeld M, Berner K, Jaeger M, Grundner-Culemann F, Schlosser P, Asberger J, Weiss D, Noethling C, Mayer S, Erbes T. Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancer. Cancer Biomark 2020;27:225-42. [PMID: 32083575 DOI: 10.3233/CBM-190575] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
86 Destounis S, Arieno A, Morgan R, Roberts C, Chan A. Qualitative Versus Quantitative Mammographic Breast Density Assessment: Applications for the US and Abroad. Diagnostics (Basel) 2017;7:E30. [PMID: 28561776 DOI: 10.3390/diagnostics7020030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
87 Sharif R, Mohammad NMA, Jia Xin Y, Abdul Hamid NH, Shahar S, Ali RAR. Dietary Risk Factors and Odds of Colorectal Adenoma in Malaysia: A Case Control Study. Nutr Cancer 2021;:1-12. [PMID: 34965818 DOI: 10.1080/01635581.2021.2022167] [Reference Citation Analysis]
88 Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-baptiste D, Saslow D, Brawley OW, Wender RC. Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening: Cancer Screening in the US, 2018. CA: A Cancer Journal for Clinicians 2018;68:297-316. [DOI: 10.3322/caac.21446] [Cited by in Crossref: 220] [Cited by in F6Publishing: 197] [Article Influence: 55.0] [Reference Citation Analysis]
89 Shahangian S, Sharma KP, Fan L, Siegel DA. Use of the prostate-specific antigen test in the U.S. for men age 30 to 64 in 2011 to 2017 using a large commercial claims database: Implications for practice interventions. Cancer Rep (Hoboken) 2021;4:e1365. [PMID: 33934557 DOI: 10.1002/cnr2.1365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Pirzadeh A, Ansari S, Golshiri P. The effects of educational intervention on breast self-examination and mammography behavior: Application of an integrated model. J Educ Health Promot 2021;10:196. [PMID: 34250130 DOI: 10.4103/jehp.jehp_1119_20] [Reference Citation Analysis]
91 Xu Y, Liu M. MicroRNA-1323 downregulation promotes migration and invasion of breast cancer cells by targeting tumour protein D52. J Biochem 2020;168:83-91. [PMID: 32211853 DOI: 10.1093/jb/mvaa035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
92 Roy S, Moss JL, Rodriguez-Colon SM, Shen C, Cooper JD, Lennon RP, Lengerich EJ, Adelman A, Curry W, Ruffin MT 4th. Examining Older Adults' Attitudes and Perceptions of Cancer Screening and Overscreening: A Qualitative Study. J Prim Care Community Health 2020;11:2150132720959234. [PMID: 33054558 DOI: 10.1177/2150132720959234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Machida H, Blake EA, Eckhardt SE, Takiuchi T, Grubbs BH, Mikami M, Roman LD, Matsuo K. Trends in single women with malignancy of the uterine cervix in United States. J Gynecol Oncol 2018;29:e24. [PMID: 29400017 DOI: 10.3802/jgo.2018.29.e24] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
94 Wang T, Liu H, Pei L, Wang K, Song C, Wang P, Ye H, Zhang J, Ji Z, Ouyang S, Dai L. Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer. Clin Immunol 2020;210:108262. [PMID: 31629809 DOI: 10.1016/j.clim.2019.108262] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
95 Liu X, Yu H, Qiao Y, Yang J, Shu J, Zhang J, Zhang Z, He J, Li Z. Salivary Glycopatterns as Potential Biomarkers for Screening of Early-Stage Breast Cancer. EBioMedicine 2018;28:70-9. [PMID: 29402727 DOI: 10.1016/j.ebiom.2018.01.026] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
96 Samuel P, Carter DR. The Diagnostic and Prognostic Potential of microRNAs in Epithelial Ovarian Carcinoma. Mol Diagn Ther 2017;21:59-73. [PMID: 27718164 DOI: 10.1007/s40291-016-0242-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
97 Qian Y, Gao J, Zhou Z, Yan J, Xu Y, Yang X, Li Y. An equity analysis of health examination service utilization by women from underdeveloped areas in western China. PLoS One 2017;12:e0186837. [PMID: 29065129 DOI: 10.1371/journal.pone.0186837] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
98 Hemminki K, Sundquist K, Sundquist J, Försti A, Hemminki A, Li X. Familial Risks and Proportions Describing Population Landscape of Familial Cancer. Cancers (Basel) 2021;13:4385. [PMID: 34503195 DOI: 10.3390/cancers13174385] [Reference Citation Analysis]
99 Kim HC, Chang J, Lee HS, Kwon HJ. Mitochondrial UQCRB as a new molecular prognostic biomarker of human colorectal cancer. Exp Mol Med 2017;49:e391. [PMID: 29147009 DOI: 10.1038/emm.2017.152] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
100 Fletcher R, Wang YJ, Schoen RE, Finn OJ, Yu J, Zhang L. Colorectal cancer prevention: Immune modulation taking the stage. Biochim Biophys Acta Rev Cancer 2018;1869:138-48. [PMID: 29391185 DOI: 10.1016/j.bbcan.2017.12.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
101 Tan W, Xie X, Li L, Tang H, Ye X, Chen L, Tang W, Gao J, Pan L, Zhang X, Ye F, Li X, Yang L, Xie X, Zheng W. Diagnostic and prognostic value of serum MACC1 in breast cancer patients. Oncotarget 2016;7:84408-15. [PMID: 27793048 DOI: 10.18632/oncotarget.12910] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
102 Zheng S, Jiang S, Chen Z, Huang Z, Shi W, Liu B, Xu Y, Guo Y, Yang H, Li M. The roles of MRI-based prostate volume and associated zone-adjusted prostate-specific antigen concentrations in predicting prostate cancer and high-risk prostate cancer. PLoS One 2019;14:e0218645. [PMID: 31743339 DOI: 10.1371/journal.pone.0218645] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Faiena I, Holden S, Cooperberg MR, Holden S, Soule HR, Simons JW, Morgan TM, Penson DF, Morgans AK, Hussain M. Prostate Cancer Screening and the Goldilocks Principle: How Much Is Just Right? J Clin Oncol 2018;36:937-41. [PMID: 29401003 DOI: 10.1200/JCO.2017.76.4050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
104 Lin CJ, Yun EJ, Lo UG, Tai YL, Deng S, Hernandez E, Dang A, Chen YA, Saha D, Mu P, Lin H, Li TK, Shen TL, Lai CH, Hsieh JT. The paracrine induction of prostate cancer progression by caveolin-1. Cell Death Dis 2019;10:834. [PMID: 31685812 DOI: 10.1038/s41419-019-2066-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
105 Fliss-Isakov N, Kariv R, Webb M, Ivancovsky D, Margalit D, Zelber-Sagi S. Mediterranean dietary components are inversely associated with advanced colorectal polyps: A case-control study. World J Gastroenterol 2018; 24(24): 2617-2627 [PMID: 29962818 DOI: 10.3748/wjg.v24.i24.2617] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
106 Lee HY, Beltran R, Kim NK, Lee DK. Racial Disparities in Cervical Cancer Screening: Implications for Relieving Cervical Cancer Burden in Asian American Pacific Islander Women. Cancer Nurs 2019;42:458-67. [PMID: 30624249 DOI: 10.1097/NCC.0000000000000642] [Reference Citation Analysis]
107 Kidess-Sigal E, Liu HE, Triboulet MM, Che J, Ramani VC, Visser BC, Poultsides GA, Longacre TA, Marziali A, Vysotskaia V, Wiggin M, Heirich K, Hanft V, Keilholz U, Tinhofer I, Norton JA, Lee M, Sollier-Christen E, Jeffrey SS. Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer. Oncotarget 2016;7:85349-64. [PMID: 27863403 DOI: 10.18632/oncotarget.13350] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 13.5] [Reference Citation Analysis]
108 Li M, Song LH, Yue GG, Lee JK, Zhao LM, Li L, Zhou X, Tsui SK, Ng SS, Fung KP, Tan NH, Lau CB. Bigelovin triggered apoptosis in colorectal cancer in vitro and in vivo via upregulating death receptor 5 and reactive oxidative species. Sci Rep 2017;7:42176. [PMID: 28181527 DOI: 10.1038/srep42176] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
109 Vieira RADC, Formenton A, Bertolini SR. Breast cancer screening in Brazil. Barriers related to the health system. Rev Assoc Med Bras (1992) 2017;63:466-74. [PMID: 28724046 DOI: 10.1590/1806-9282.63.05.466] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
110 Sewitch MJ, Azalgara VM, Sing MF. Screening Indication Associated With Lower Likelihood of Minor Adverse Events in Patients Undergoing Outpatient Colonoscopy. Gastroenterol Nurs 2018;41:159-64. [PMID: 29596130 DOI: 10.1097/SGA.0000000000000308] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
111 Walter JE, Heuvelmans MA, Bock GH, Yousaf-Khan U, Groen HJM, Aalst CMV, Nackaerts K, Ooijen PMAV, Koning HJ, Vliegenthart R, Oudkerk M. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study. Thorax 2018;73:741-7. [PMID: 29661918 DOI: 10.1136/thoraxjnl-2017-211376] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
112 Lipkus IM, Johnson CM, Amarasekara S, Pan W, Updegraff JA. Reactions to online colorectal cancer risk estimates among a nationally representative sample of adults who have never been screened. J Behav Med 2018;41:289-98. [PMID: 29143218 DOI: 10.1007/s10865-017-9902-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
113 Eastland TY. A Survey of the Knowledge of African-American Women About Prostate Cancer Screening. J Cancer Educ 2018;33:1115-9. [PMID: 28391558 DOI: 10.1007/s13187-017-1220-9] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
114 Li S, Xie L, He L, Fan Z, Xu J, Xu K, Zhu L, Ma G, Du M, Chu H, Zhang Z, Ni M, Wang M. Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer. J Cancer 2017;8:1355-61. [PMID: 28638449 DOI: 10.7150/jca.18014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
115 Olasehinde O, Alatise OI, Arowolo OA, Mango VL, Olajide OS, Omisore AD, Boutin-Foster C, Kingham TP. Barriers to mammography screening in Nigeria: A survey of two communities with different access to screening facilities. Eur J Cancer Care (Engl) 2019;28:e12986. [PMID: 30614109 DOI: 10.1111/ecc.12986] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
116 Li Y, Fan M, Cheng H, Zhang P, Zheng B, Li L. Assessment of global and local region-based bilateral mammographic feature asymmetry to predict short-term breast cancer risk. Phys Med Biol 2018;63:025004. [PMID: 29226849 DOI: 10.1088/1361-6560/aaa096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
117 Olasehinde O, Boutin-Foster C, Alatise OI, Adisa AO, Lawal OO, Akinkuolie AA, Adesunkanmi AK, Arije OO, Kingham TP. Developing a Breast Cancer Screening Program in Nigeria: Evaluating Current Practices, Perceptions, and Possible Barriers. J Glob Oncol 2017;3:490-6. [PMID: 29094087 DOI: 10.1200/JGO.2016.007641] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
118 Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271-289. [PMID: 27253694 DOI: 10.3322/caac.21349] [Cited by in Crossref: 2633] [Cited by in F6Publishing: 2638] [Article Influence: 438.8] [Reference Citation Analysis]
119 Urban LABD, Chala LF, Bauab SDP, Schaefer MB, Dos Santos RP, Maranhão NMA, Kefalas AL, Kalaf JM, Ferreira CAP, Canella EO, Peixoto JE, de Amorim HLE, de Camargo Junior HSA. Breast cancer screening: updated recommendations of the Brazilian College of Radiology and Diagnostic Imaging, Brazilian Breast Disease Society, and Brazilian Federation of Gynecological and Obstetrical Associations. Radiol Bras 2017;50:244-9. [PMID: 28894332 DOI: 10.1590/0100-3984.2017-0069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
120 Shahangian S, Fan L, Sharma KP, Siegel DA. Use of the prostate-specific antigen (PSA) test in the United States for men age ≥65, 1999-2015: Implications for practice interventions. Cancer Rep (Hoboken) 2021;4:e1352. [PMID: 33932150 DOI: 10.1002/cnr2.1352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
121 Levy BT, Daly JM, Xu Y, Crockett SD, Hoffman RM, Dawson JD, Parang K, Shokar NK, Reuland DS, Zuckerman MJ, Levin A. Comparative effectiveness of five fecal immunochemical tests using colonoscopy as the gold standard: study protocol. Contemp Clin Trials 2021;106:106430. [PMID: 33974994 DOI: 10.1016/j.cct.2021.106430] [Reference Citation Analysis]
122 Granados R, Tellez-Safina H, Solis I, Mateos F, Rodriguez-Barbero JM, Aramburu JA, Huertas MA, Bajo P, Camarmo E, Corrales T, Medina P, Calvo B, Martin E, Anta L, Zamora M, Alcaide T. Cervical cancer screening cotesting with cytology and MRNA HPV E6/E7 yields high rates of CIN2+ lesions in young women. Diagn Cytopathol 2017;45:1065-72. [PMID: 28949442 DOI: 10.1002/dc.23821] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
123 Ambe PC, Jansen S, Zirngibl H. New trend in colorectal cancer in Germany: are young patients at increased risk for advanced colorectal cancer? World J Surg Oncol. 2017;15:159. [PMID: 28835275 DOI: 10.1186/s12957-017-1227-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
124 Muller CJ, Robinson RF, Smith JJ, Jernigan MA, Hiratsuka V, Dillard DA, Buchwald D. Text message reminders increased colorectal cancer screening in a randomized trial with Alaska Native and American Indian people. Cancer 2017;123:1382-9. [PMID: 28001304 DOI: 10.1002/cncr.30499] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
125 Demb J, Akinyemiju T, Allen I, Onega T, Hiatt RA, Braithwaite D. Screening mammography use in older women according to health status: a systematic review and meta-analysis. Clin Interv Aging 2018;13:1987-97. [PMID: 30349218 DOI: 10.2147/CIA.S171739] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
126 Davis C, Darby K, Moore M, Cadet T, Brown G. Breast care screening for underserved African American women: Community-based participatory approach. J Psychosoc Oncol 2017;35:90-105. [PMID: 27662263 DOI: 10.1080/07347332.2016.1217965] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
127 Shi J, Li D, Liang D, He Y. Epidemiology and prognosis in young lung cancer patients aged under 45 years old in northern China. Sci Rep 2021;11:6817. [PMID: 33767239 DOI: 10.1038/s41598-021-86203-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
128 Xu L, Lu Z, Yu S, Li G, Chen Y. Quantitative global proteome and phosphorylome analyses reveal potential biomarkers in kidney cancer. Oncol Rep 2021;46:237. [PMID: 34528699 DOI: 10.3892/or.2021.8188] [Reference Citation Analysis]
129 Tian T, Wang M, Lin S, Guo Y, Dai Z, Liu K, Yang P, Dai C, Zhu Y, Zheng Y, Xu P, Zhu W, Dai Z. The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis. Mol Ther Nucleic Acids 2018;12:359-69. [PMID: 30195774 DOI: 10.1016/j.omtn.2018.05.018] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
130 Lewis-Patterson P, Palos GR, Dains J, Jackson TL. Cancer Prevention in the Survivorship Setting. Semin Oncol Nurs 2016;32:291-305. [PMID: 27539283 DOI: 10.1016/j.soncn.2016.05.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
131 Long Q, Lin TY, Huang Y, Li X, Ma AH, Zhang H, Carney R, Airhart S, Lam KS, deVere White RW, Pan CX, Li Y. Image-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model. Nanomedicine 2018;14:789-99. [PMID: 29317342 DOI: 10.1016/j.nano.2017.12.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
132 Ezema RN, Igbokwe CC, Iwuagwu TE, Agbaje OS, Ofuebe JI, Abugu LI, Eze DD, Wamanyi Y. Association of Sociodemographic Factors, Breast Cancer Fear, and Perceived Self-Efficacy With Breast Cancer Screening Behaviors Among Middle-Aged Nigerian Women. Breast Cancer (Auckl) 2021;15:11782234211043651. [PMID: 34616153 DOI: 10.1177/11782234211043651] [Reference Citation Analysis]
133 Burnell SEA, Spencer-Harty S, Howarth S, Bodger O, Kynaston H, Morgan C, Doak SH. STEAP2 Knockdown Reduces the Invasive Potential of Prostate Cancer Cells. Sci Rep 2018;8:6252. [PMID: 29674723 DOI: 10.1038/s41598-018-24655-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
134 Tentori K, Pighin S, Divan C, Crupi V. Mind the gap: Physicians' assessment of patients' importance weights in localized prostate cancer. PLoS One 2018;13:e0200780. [PMID: 30048485 DOI: 10.1371/journal.pone.0200780] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
135 Tonorezos ES, Friedman DN, Barnea D, Bosscha MI, Chantada G, Dommering CJ, de Graaf P, Dunkel IJ, Fabius AWM, Francis JH, Greer MC, Kleinerman RA, Kors WA, Laughlin S, Moll AC, Morton LM, Temming P, Tucker MA, van Leeuwen FE, Walsh MF, Oeffinger KC, Abramson DH. Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma. Ophthalmology 2020;127:1549-57. [PMID: 32422154 DOI: 10.1016/j.ophtha.2020.05.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
136 Brinton JT, Hendrick RE, Ringham BM, Kriege M, Glueck DH. Improving the diagnostic accuracy of a stratified screening strategy by identifying the optimal risk cutoff. Cancer Causes Control 2019;30:1145-55. [PMID: 31377875 DOI: 10.1007/s10552-019-01208-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
137 Cao H, Feng Y, Chen L, Yu C. Lobaplatin Inhibits Prostate Cancer Proliferation and Migration Through Regulation of BCL2 and BAX. Dose Response 2019;17:1559325819850981. [PMID: 31217754 DOI: 10.1177/1559325819850981] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
138 Lin Y, Liu G, Liu C, Xie H, Wang X, Huang Y, Jin L, Chen H. Urothelial carcinoembryonic antigen 1 score for early detection of prostate cancer and risk prediction. Cancer Med 2022. [PMID: 35289508 DOI: 10.1002/cam4.4629] [Reference Citation Analysis]
139 Moss JL, Roy S, Shen C, Cooper JD, Lennon RP, Lengerich EJ, Adelman A, Curry W, Ruffin MT 4th. Geographic Variation in Overscreening for Colorectal, Cervical, and Breast Cancer Among Older Adults. JAMA Netw Open 2020;3:e2011645. [PMID: 32716514 DOI: 10.1001/jamanetworkopen.2020.11645] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
140 Fliss-Isakov N, Zelber-Sagi S, Webb M, Halpern Z, Kariv R. Smoking Habits are Strongly Associated With Colorectal Polyps in a Population-based Case-control Study. J Clin Gastroenterol 2018;52:805-11. [PMID: 29210901 DOI: 10.1097/MCG.0000000000000935] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
141 Peng L, Cantor DI, Huang C, Wang K, Baker MS, Nice EC. Tissue and plasma proteomics for early stage cancer detection. Mol Omics 2018;14:405-23. [DOI: 10.1039/c8mo00126j] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
142 Navarro M, Nicolas A, Ferrandez A, Lanas A. Colorectal cancer population screening programs worldwide in 2016: An update. World J Gastroenterol 2017; 23(20): 3632-3642 [PMID: 28611516 DOI: 10.3748/wjg.v23.i20.3632] [Cited by in CrossRef: 202] [Cited by in F6Publishing: 167] [Article Influence: 40.4] [Reference Citation Analysis]
143 García-Albéniz X, Hsu J, Hernán MA. The value of explicitly emulating a target trial when using real world evidence: an application to colorectal cancer screening. Eur J Epidemiol 2017;32:495-500. [PMID: 28748498 DOI: 10.1007/s10654-017-0287-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
144 Kelly SP, Anderson WF, Rosenberg PS, Cook MB. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States. Eur Urol Focus 2018;4:121-7. [PMID: 29162421 DOI: 10.1016/j.euf.2017.10.014] [Cited by in Crossref: 82] [Cited by in F6Publishing: 81] [Article Influence: 16.4] [Reference Citation Analysis]
145 Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-baptiste D, Saslow D, Brawley OW, Wender RC. Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening: Cancer Screening in the U.S., 2017. CA: A Cancer Journal for Clinicians 2017;67:100-21. [DOI: 10.3322/caac.21392] [Cited by in Crossref: 227] [Cited by in F6Publishing: 201] [Article Influence: 45.4] [Reference Citation Analysis]
146 Li S, Yin L, Huang K, Zhao Y, Zhang H, Cai C, Xu Y, Huang L, Wang X, Lan T, Li H, Ma P. Downregulation of DACT-2 by Promoter Methylation and its Clinicopathological Significance in Prostate Cancer. J Cancer 2019;10:1755-63. [PMID: 31205531 DOI: 10.7150/jca.28577] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
147 Sait KHW, Alam Q, Anfinan N, Al-Ghamdi O, Malik A, Noor R, Jahan F, Tarique M. Structure-based virtual screening and molecular docking for the identification of potential novel EGFRkinase inhibitors against ovarian cancer. Bioinformation 2019;15:287-94. [PMID: 31285646 DOI: 10.6026/97320630015287] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
148 Naber SK, Kundu S, Kuntz KM, Dotson WD, Williams MS, Zauber AG, Calonge N, Zallen DT, Ganiats TG, Webber EM, Goddard KAB, Henrikson NB, van Ballegooijen M, Janssens ACJW, Lansdorp-Vogelaar I. Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future Potential. JNCI Cancer Spectr 2020;4:pkz086. [PMID: 32025627 DOI: 10.1093/jncics/pkz086] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]